Nationwide Children's Hospital
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Nationwide Children's Hospital sits in the top decile of US sponsors by registered trial count (#158 of 15,742 sponsors by registered trial count).
Nationwide Children's Hospital: 188 sponsored US clinical trials, 29 recruiting.
Nationwide Children's Hospital sponsors 188 registered US clinical trials on ClinicalTrials.gov, 29 of them currently recruiting, and 122 completed. 13 of these trials are in Phase 3-4 (later-stage) and 50 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is High Grade Glioma, with 8 trials.
Top-decile sponsor footprint
Nationwide Children's Hospital ranks in the top decile of sponsors by registered trial count (#158 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
122 of 143 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (85.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
188 total, page 4 of 4
Retrospective Femoral Nerve Block Study
NCT01293136
Safe Play Areas for Ross County Kids Project
NCT01291225
Impact of Using a Cuffed Endotracheal Tube on Limiting the Risk of Airway Fire
NCT01285804
Dexmedetomidine Versus Fentanyl Following Pressure Equalization Tube Placement
NCT01188551
Masimo CO-Oximeter Study
NCT01184521
A Reduced Toxicity Allogeneic Unrelated Donor Stem Cell Transplantation (SCT) for Severe Sickle Cell Disease
NCT01279616
Critical Smoke Alarm Characteristics to Awaken Children From Stage 4 Sleep
NCT01169155
Gemcitabine, Paclitaxel and Oxaliplatin (GemPOx)
NCT01270724
Three Times Weekly (TIW) Growth Hormone Therapy in Children on Hemodialysis
NCT00943995
Pediatric Alliance for International Neurogastrointestinal Functional Research
NCT01099787
Review of Pain Management After Congenital Cardiac Surgery
NCT01378663
Gastric Accommodation and Gastroesophageal Reflux
NCT01078064
Repeated Infusions of Mesenchymal Stromal Cells in Children With Osteogenesis Imperfecta
NCT01061099
Reducing Antipsychotic-Induced Weight Gain in Children With Metformin
NCT01231074
Contingency Management for Smoking Abstinence With Adolescent Smokers
NCT01056588
A Comparison of Early Mobilization Versus Traditional Treatment for Acute Ankle Sprains.
NCT01134653
Use of an Ambulatory Capsule to Characterize Gastrointestinal Pressure Patterns in Children
NCT01026922
Impaired Insulin-like Growth Factor-1 (IGF-1) Generation Causes Protein Catabolism and Poor Growth in Children With Crohn Disease
NCT00946361
Impaired Family Dynamics Leads to Non Compliance in Type I Diabetes
NCT00946517
Cardiomyopathy in DMD: Lisinopril vs. Losartan
NCT01982695
Metabolic Syndrome in Bone Marrow Transplant Survivors
NCT00855244
Measures to Lower the Stress Response in Pediatric Cardiac Surgery
NCT00848393
Functional Magnetic Resonance Imaging (fMRI) Findings in Children With Early Exposure to General Anesthesia
NCT01229514
Effect of Increlex® on Children With Crohn Disease
NCT00764699
Treatment Follow-up Study
NCT00995696
Use of Levemir® Improves Metabolic and Clinical Status in Cystic Fibrosis-related Diabetes (CFRD)
NCT00639626
Predictors of Teen Smoking-cessation
NCT01141517
Gene Transfer Therapy for Treating Children and Adults With Limb Girdle Muscular Dystrophy Type 2D (LGMD2D)
NCT00494195
Growth Hormone in Children With Juvenile Rheumatoid Arthritis (JRA) and With Crohn's Disease
NCT00511329
Six Month Study of Gentamicin in Duchenne Muscular Dystrophy With Stop Codons
NCT00451074
Safety Study of Mini-dystrophin Gene to Treat Duchenne Muscular Dystrophy
NCT00428935
HTRS TE Registry (ThromboEmbolism Registry)
NCT00266994
Randomized Trial of Hydrocortisone in Very Preterm High-Risk Infants
NCT00167544
Trial of Automated Risk Appraisal for Adolescents
NCT00505440
Genetic Characterization of Individuals With Limb Girdle Muscular Dystrophy
NCT00457912
Anticipatory Guidance to Prevent Childhood Obesity
NCT01565525
Effectiveness of Pulmozyme in Infants With Cystic Fibrosis
NCT00179998
Short Term Outcomes of Children With Acute Respiratory Distress Syndrome
NCT00142376
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 21 |
| Phase 2 | 29 |
| Phase 3 | 8 |
| Phase 4 | 5 |
Therapeutic Areas
What is open in the Nationwide Children's Hospital pipeline
29 recruiting of 188 indexed (15% open); 122 completed (65%).
Phase mix: 13 late (III/IV) vs 50 early (I/II) (early-phase heavy).
Top condition: High Grade Glioma (8 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Nationwide Children's Hospital: open-pipeline peers nationwide
Peers matched on 188 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
Nationwide Children's Hospital sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 188 trials (± recruiting share)
- Vanderbilt-Ingram Cancer Center · 189 trials · 15% recruiting
- Arizona State University · 187 trials · 15% recruiting
- Johns Hopkins Bloomberg School of Public Health · 187 trials · 14% recruiting
- Vertex Pharmaceuticals Incorporated · 191 trials · 10% recruiting
Sponsors near 15% open enrollment (± trial volume)
- University of Michigan Rogel Cancer Center · 15% recruiting · 292 trials
- Arrowhead Regional Medical Center · 15% recruiting · 13 trials
- Aurinia Pharmaceuticals · 15% recruiting · 13 trials
- Bronx VA Medical Center · 15% recruiting · 13 trials
Related
What to do with this Nationwide Children's Hospital page
188 registered trials is a research-attention snapshot, not an endorsement of Nationwide Children's Hospital or any single study.
- 29 of Nationwide Children's Hospital's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- High Grade Glioma is the condition Nationwide Children's Hospital studies most, compare against other sponsors active in the same condition before evaluating a specific study. See High Grade Glioma trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Nationwide Children's Hospital pipeline card: 188 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.